Find Your Script
MARCH 26, 2022
Are you a pharmacy student about to start APPE rotations? In this video, I’ll talk about my 4 steps to have successful APPE rotations. Stay until the end for my most important step. Watch & Subscribe on our YouTube Channel ! [link]. Hi, I’m Dr. Jessica Louie and I’m an Associate Professor, Board-Certified Critical Care Pharmacist and entrepreneur.
pharmaphorum
MARCH 30, 2022
Data from a massive real-world study of asthma patients has suggested that overuse of inhalers is widespread and leading to an elevated risk of severe exacerbations. The results from the SABINA registry programme in more than a million people with the respiratory disease show that 40% of patients were over-using short-acting beta agonist (SABA) inhalers, which are used on demand to open up the airways.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
MARCH 31, 2022
A renowned university researcher explains the path that laid the foundation and what the novel diagnostic and treatment means for prostate cancer patients.
Fossil Remedies
MARCH 29, 2022
It is every entrepreneur’s dream to launch a business that earns a great profit. After all that is something, which everyone aims for. The pharma business has become one of the most popular businesses in the last 20 years. Why? It is because the pharma sector has done remarkably well. Also, it shows signs of good growth in the next few years. If you consider a few data facts, then the pharma sector today around 40+ Billion dollars , and in the next few years, it will cross even 100 Billion dolla
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Tutor
MARCH 26, 2022
A REVIEW ON CLINICAL DATA MANAGEMENT : CURRENT STATUS IN CLINICAL RESEARCH. About Authors. MANISHA KOTADIYA*, JAYDEEP SAVALIYA. *Shree Swaminarayan Sanskar Collage of Pharmacy Zundal, Gandhinagar, Gujarat, Email Id: manishakotadiya3@gmail.com, FTF Pharma Pvt. Ltd. – Ahmedabad, Email ID: jaydeepsavaliya27@gmail.com. admin. Sat, 03/26/2022 - 17:13. Tags.
pharmaphorum
MARCH 31, 2022
University College Dublin spinout Kinesis Health Technologies, which has developed a range of wearable sensors to assess the physical capabilities of patients, has been bought by US company Linus Health for an undisclosed sum. The merger brings together Kinesis’ gait analysis tools with Linus’ digital brain health monitoring technologies, designed to spot diseases like Alzheimer’s before over symptoms develop.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Times
MARCH 30, 2022
Report uses input from healthcare professionals to highlight training and support needs, while also warning about departures
Pharma Mirror
MARCH 31, 2022
It all started in March 2020 and it is now Jan 2022. We still can’t declare the COVID pandemic as “finished”. How has the pandemic impacted the field marketing activity of Pharma companies? What should the industry do to prepare for what will definitely be a new world, post-COVID? There were many analysts who, even before the pandemic, were saying that the role of Medical Representatives will reduce.
pharmaphorum
APRIL 1, 2022
With the new Health and Care Bill edging ever closer to receiving Royal Assent, life sciences companies in the UK are preparing to navigate the most significant piece of NHS legislation in a decade. The new bill, which is expected to come into force on 1st July, will see Clinical Commissioning Groups replaced with Integrated Care Systems (ICSs) as statutory bodies across England.
Outsourcing Pharma
MARCH 29, 2022
The agency's requested funding for FY 2023, nearly 34% higher than for FY 2022, calls for investments in public health modernization and pandemic preparation.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmD Live
MARCH 30, 2022
Aging is a privilege, not a guarantee–Chronic Care Management improves quality of life. By Marshall Eidenberg, DO, MBA. As one has the privilege to get older, chronic conditions will go up. Typically, one per decade after one’s 30s. Each situation typically involves one or more medications for each chronic health condition. And with more medicines, the risk of interaction and adverse drug events increases.
Pharma Mirror
MARCH 31, 2022
The leading European pharmaceutical marketplace now hosts more than 85 000 CTD dossiers for finished dosage formulation products. Compared to 19 600 products at the start of 2021, the product offering has increased fourfold over a single year. As a response to increasing demand, Pipelinepharma will introduce biosimilar drugs into a separate category.
pharmaphorum
MARCH 28, 2022
Israel-based AION Labs and German independent research institute BioMed X announced its third global call for applications to form a new start-up company focused on using AI to design and optimise antibodies for targeted therapies. . Noga Yerushalmi, investment director at M Ventures (the venture arm of Merck), tells us how AION Labs was formed and aspires to help ease the pharma industry’s shared challenges by offering its vast resources a new start-up.
Outsourcing Pharma
MARCH 31, 2022
An expert from the clinical technology solutions provider discusses some of the top challenges associated with technology adoption, and how to tackle them.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
McCreadie Group
MARCH 30, 2022
April 2022 | Mindy Suttlemyre, BS, PhT I was honored to present “Off the Beaten Path: Exploring Opportunities for Technicians within IDS Pharmacy” at McCreadie Group’s 2021 Research Pharmacy Summit. When asked to be a speaker, I was working at The University of Utah/Huntsman Cancer Hospital IDS as the Lead Pharmacy Technician and was eager to. The post My Rewarding Path as a Pharmacy Technician: A Reflection on Career Growth and Opportunity appeared first on McCreadie Group Blog.
Pharma Mirror
MARCH 31, 2022
Symbiosis Pharmaceutical Services Ltd (Symbiosis), a fast-growing contract manufacturing organisation (CMO) specialising in sterile global manufacture of pharmaceuticals, vaccines and biopharmaceuticals including Advanced Therapeutical Medicinal Products (ATMPs), has announced the completion of a £1.3 million collaborative UKRI-funded project as part of the medicines manufacturing challenge.
pharmaphorum
MARCH 31, 2022
Leading tennis players train two to three hours a day to prepare for tournaments and have daily coaching input to make them game ready. It’s a gruelling regime but the rewards are obvious. Competing at the top level in pharma sales could be developed by following in the fast footsteps of Roger Federer and Rafael Nadal. Experts believe time spent practising delivery and messaging will reap dividends providing it is grooved into a sales force or medical science liaison (MSL) team’s schedule.
Board Vitals - Pharmacist
MARCH 29, 2022
Our lives are often divided into chapters, delineated by specific transition points. Much like blood flowing through our circulatory system, the trajectory of our lives can be turbulent at times while laminer at others. It can advance and progress, but can also be met with opposition and obstruction. It is in those watershed moments when we recall a notable difference, a growth.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
NF2 BioSolutions
MARCH 29, 2022
– Everyone’s journey with NF2 is different. No 2 cases are the same. The biggest problem we face is the ‘unknown’ and never knowing what’s around the corner for us. After being diagnosed and going through a whirlwind of emotions. I decided to start looking into new activities/hobbies to try, looking for something physical so that I could try and keep my body strong and active. – – Ice hockey is something that I’d always wanted to try, but was never
Pharma Marketing Network
MARCH 29, 2022
Pharmaceutical companies have been successful for decades with a siloed marketing strategy. Rep-led field engagement, television advertising, and digital marketing have all been planned, executed, and measured separately, but customer expectations are changing fast. With the pandemic and the shift to mobile devices, customers are demanding more convenient and seamless ways to interact with pharma companies.
pharmaphorum
MARCH 31, 2022
By a narrow margin, an FDA advisory committee has voted against approval of Amylyx’ experimental medicine for amyotrophic lateral sclerosis until the company can provide more evidence that it is effective. The prospects of a positive vote on AMX0035 (sodium phenylbutyrate and taurursodiol) were looking dim after the FDA expressed its doubts about the efficacy data in Amylyx’ single 140-subject study, although the desperate need for new treatments for ALS had the company hopeful it ha
Pharma Mirror
MARCH 29, 2022
Karlsruhe/Germany, Romaco Macofar’s Oftalmica was specially developed for aseptic filling of sterile eye drops, nasal sprays and injectables. Meeting all GMP requirements for safe processing of highly viscous, oily and foaming liquids, the machine additionally offers fast format changes and short cleaning times. The Oftalmica is Romaco Macofar’s latest technology for aseptic filling of sterile eye drops.
Outsourcing Pharma
MARCH 28, 2022
The companies plan to work on developing personalized care solutions via digital pathology to come up with treatment options for patients with solid tumors.
Pharma Marketing Network
MARCH 29, 2022
Tune in to this episode of the Pharma marketing Podcast, with our guest Wendy Pease, President of Rapport International and the author of The Language of Global Marketing for a conversation on why pharma should be thinking global from the start, addressing how to keep a consistent brand globally, and the many things that need to be considered when curating your global market.
pharmaphorum
MARCH 27, 2022
Johnson & Johnson is in course for approval of its multiple myeloma CAR-T therapy Carvykti in the EU the next few weeks, after getting a green light from the EMA’s human medicines committee. The CHMP recommended conditional approval for Carvykti (ciltacabtagene autoleucel or cilta-cel) as a treatment for adults with relapsed and refractory multiple myeloma who have received at least three prior therapies and whose cancer is worsening.
Pharma Mirror
MARCH 29, 2022
NIEL, BELGIUM, eTheRNA Manufacturing, a specialist RNA process developer and manufacturing member of the Belgian eTheRNA group, is introducing a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and early pre-clinical development of RNA-based therapeutics and vaccines. This new LNP service uses eTheRNA’s proprietary lipid libraries and proprietary formulations to facilitate targeted delivery and tailored biodistribution solutions.
Outsourcing Pharma
MARCH 28, 2022
A new study will seek to understand the bodyâs response to the Nipah virus in order to support development of vaccines.
Roots Analysis
MARCH 28, 2022
Over the last few decades, the pharmaceutical industry has been using batch processes for production of pharmaceutical products, which is a multi-phase process. However, the surge in the demand for drugs due to COVID-19 has led the pharmaceutical industry to shift on to a more agile and flexible technique- continuous, which is a single flow process allowing the industry to scale up quick, manufacture easily and shortens the drug supply chain.
pharmaphorum
MARCH 30, 2022
Roche has suffered a setback with its much-anticipated pairing of anti-TIGIT antibody tiragolumab and PD-L1 inhibitor Tecentriq in small cell lung cancer (SCLC), in a blow to its ambitions in combination cancer immunotherapy. The SKYSCRAPER-02 showed that the combination of the two drugs given on top of chemotherapy was unable to improve progression-free survival versus Tecentriq (atezolizumab) plus chemo in extensive-stage SCLC – a notoriously hard-to-treat form of lung cancer.
Pharma Mirror
MARCH 27, 2022
BARCELONA, Spain, More than 50 percent of patients with moderate-to-severe atopic dermatitis (AD) experienced at least 75 percent reduction in disease severity (EASI-75*) at 16 weeks when receiving lebrikizumab monotherapy in the ADvocate program, Almirall S.A. (BME: ALM) announced today at the American Academy of Dermatology (AAD) Annual Meeting. Lebrikizumab, an investigational IL-13 inhibitor, also led to clinically meaningful improvements in itch and other important patient-reported outcomes
Outsourcing Pharma
MARCH 28, 2022
The drug has received the agencyâs seal of approval to treat seizures associated with difficult-to-treat seizures associated with Lennox-Gastaut syndrome.
Pharma Times
MARCH 30, 2022
ProKnow was chosen to enable healthcare providers to benchmark treatment metrics against best practice and support clinical excellence
pharmaphorum
MARCH 29, 2022
With the rapid onset of the pandemic, the race to develop a viable vaccine quickly became a race to secure access to the developed vaccines. In this article, Ben Hargreaves examines how wealth determined the winners and what is now underway to help lower-income countries gain access to the available vaccines. At the beginning of the pandemic, there were two principal issues facing producing an effective vaccine: how can one be quickly developed, and how can production meet global demand?
Expert insights. Personalized for you.
130 
Let's personalize your content